“…In order to improve completeness, 5 research reports, 3 of which were published before 1990, and 2 recent papers on BT and surgical history were added [13,14,15,16,17]. Thirty-three documents pertaining to case-control studies and several studied cohorts [4,5,6,7,8,9,10,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38] were examined in full text. Thirteen were excluded from the systematic review since: (a) they focused on biographic residential space-time relationships [19]; (b) they were methodological [6,7,8,20]; (c) they focused on the follow-up of national single cohorts of persons exposed to treatment with human pituitary growth hormones in the UK, The Netherlands and the USA [18,21,22,23,24], or with BT or plasma products without data on nonexposed persons [37,38], or (d) they related to human dura mater graft recipients [25].…”